logo-loader
viewArcadia Biosciences Inc

Full interview: Arcadia Biosciences debuts new GoodHemp product line, already seeing high demand

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matt Plavan tells Proactive the California-based company has launched a new product line called GoodHemp.

Plavan says GoodHemp is the company's new hemp seed, transplants, flower and extracts brand, and its first commercial product is a disease-resistant and ultra-low THC hemp seed called Complia Bot+. Plavan says he's seeing a very high demand for the product, anticipating it to sell out.

Quick facts: Arcadia Biosciences Inc

Price: 5.26 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $45.48 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences records some big wins in the 3rd Quarter

Arcadia Biosciences (NASDAQ: RKDA) CEP Matt Plavan joined Proactive’s Steve Darling to discuss the company’s third-quarter results. Plavan also discussed some of the company highlights during that quarter including the latest on their research facilities. Plavan also discussed their hemp...

on 11/07/2019

2 min read